On Wednesday, Novo Nordisk A/S ( NVO ) announced that the CLARION-CKD phase 3 trial failed to meet its primary endpoint. CLARION-CKD was a multicenter, double-blind, placebo-controlled, randomized phase 3 study of ocedurenone for uncontrolled hypertension in patients with advanced chronic kidney disease (CKD). Also Read: Novo Nordisk Releases Data Showing Ozempic For Diabetes Slows Kidney Disease Progression. CLARION-CKD follows...

ANEW Medical, Inc. ( WENA ) shares are trading higher Wednesday after the company has announced the issuance of a significant patent in Europe. What’s Going On: The patent, EP3377091B1, covers the use of ANEW’s secreted Klotho gene sequence and gene delivery systems for treating diminished cognition, memory loss, dementia and other neurodegenerative diseases. This crucial intellectual property asset was...

Deep-pocketed investors have adopted a bearish approach towards RTX , and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in RTX usually suggests something big is about to happen. We gleaned this information from our observations today...

(Reuters) -Amazon.com plans to launch a section on its shopping site featuring cheap items that ship directly to overseas consumers from warehouses in China, the Information reported on Wednesday, citing slides shown to Chinese sellers. The new marketplace, Amazon's ( AMZN ) most aggressive response to the growth of bargain sites like Temu and Shein, will offer unbranded fashion, home...